|
1
|
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
|
N Engl J Med
|
2003
|
10.57
|
|
2
|
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.
|
N Engl J Med
|
2004
|
9.13
|
|
3
|
Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction.
|
Hypertension
|
2007
|
2.22
|
|
4
|
Albuminuria response to very high-dose valsartan in type 2 diabetes mellitus.
|
J Hypertens
|
2007
|
2.12
|
|
5
|
Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction.
|
Eur J Heart Fail
|
2006
|
1.22
|
|
6
|
Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo study.
|
Eur Heart J
|
2008
|
1.16
|
|
7
|
First clinical application of an actively reversible direct factor IXa inhibitor as an anticoagulation strategy in patients undergoing percutaneous coronary intervention.
|
Circulation
|
2010
|
1.00
|
|
8
|
Demographic determinants and effect of pre-operative angiotensin converting enzyme inhibitors and angiotensin receptor blockers on the occurrence of atrial fibrillation after CABG surgery.
|
BMC Cardiovasc Disord
|
2010
|
0.80
|
|
9
|
A noninferiority comparison of valsartan/hydrochlorothiazide combination versus amlodipine in black hypertensives.
|
Hypertension
|
2005
|
0.77
|